These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 10194104

  • 1. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA, Siddiqui F, Stosor V, Kruzynski J, Peterson LR.
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract] [Full Text] [Related]

  • 2. Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
    McNeil SA, Clark NM, Chandrasekar PH, Kauffman CA.
    Clin Infect Dis; 2000 Feb; 30(2):403-4. PubMed ID: 10671355
    [No Abstract] [Full Text] [Related]

  • 3. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J, Zick G, Klare I, Konstabel C, Weiler N, Sahly H.
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [Abstract] [Full Text] [Related]

  • 4. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
    Le J, Bookstaver PB, Rudisill CN, Hashem MG, Iqbal R, James CL, Sakoulas G.
    Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
    [Abstract] [Full Text] [Related]

  • 5. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM.
    Clin Infect Dis; 2003 Feb 15; 36(4):473-81. PubMed ID: 12567306
    [Abstract] [Full Text] [Related]

  • 6. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M, Wixson RL, Pertel PE.
    Clin Infect Dis; 2002 May 15; 34(10):1412-4. PubMed ID: 11981739
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
    Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S.
    Clin Infect Dis; 2001 May 01; 32(9):1373-5. PubMed ID: 11303275
    [Abstract] [Full Text] [Related]

  • 8. First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
    Liao CH, Tseng SP, Fang CT, Teng LJ, Hsueh PR.
    J Antimicrob Chemother; 2005 Apr 01; 55(4):598-9. PubMed ID: 15728149
    [No Abstract] [Full Text] [Related]

  • 9. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA, Wysome J, West AP, Heritage J, Wilcox MH.
    J Antimicrob Chemother; 2006 Apr 01; 57(4):767-70. PubMed ID: 16464896
    [Abstract] [Full Text] [Related]

  • 10. Linezolid resistant enterococcus faecium.
    McNicholas S, Hanahoe B, Higgins F, McAnena O, Corbett-Feeney G, Cormican M.
    Ir Med J; 2008 Apr 01; 101(7):225-6. PubMed ID: 18810787
    [No Abstract] [Full Text] [Related]

  • 11. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
    Zeana C, Kubin CJ, Della-Latta P, Hammer SM.
    Clin Infect Dis; 2001 Aug 15; 33(4):477-82. PubMed ID: 11462183
    [Abstract] [Full Text] [Related]

  • 12. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
    Gonzales RD, Schreckenberger PC, Graham MB, Kelkar S, DenBesten K, Quinn JP.
    Lancet; 2001 Apr 14; 357(9263):1179. PubMed ID: 11323048
    [Abstract] [Full Text] [Related]

  • 13. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
    Bae HG, Sung H, Kim MN, Lee EJ, Koo Lee S.
    Scand J Infect Dis; 2006 Apr 14; 38(5):383-6. PubMed ID: 16709544
    [Abstract] [Full Text] [Related]

  • 14. Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
    Schülin T, Thauvin-Eliopoulos C, Moellering RC, Eliopoulos GM.
    Antimicrob Agents Chemother; 1999 Dec 14; 43(12):2873-6. PubMed ID: 10582874
    [Abstract] [Full Text] [Related]

  • 15. Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
    King ST, Usery JB, Holloway K, Koeth L, Cleveland KO, Gelfand MS.
    J Antimicrob Chemother; 2011 Nov 14; 66(11):2673-5. PubMed ID: 21846674
    [No Abstract] [Full Text] [Related]

  • 16. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
    Herrero IA, Issa NC, Patel R.
    N Engl J Med; 2002 Mar 14; 346(11):867-9. PubMed ID: 11893808
    [No Abstract] [Full Text] [Related]

  • 17. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
    Chien JW, Kucia ML, Salata RA.
    Clin Infect Dis; 2000 Jan 14; 30(1):146-51. PubMed ID: 10619743
    [Abstract] [Full Text] [Related]

  • 18. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
    Pai MP, Rodvold KA, Schreckenberger PC, Gonzales RD, Petrolatti JM, Quinn JP.
    Clin Infect Dis; 2002 Nov 15; 35(10):1269-72. PubMed ID: 12410489
    [Abstract] [Full Text] [Related]

  • 19. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
    Melzer M, Goldsmith D, Gransden W.
    Clin Infect Dis; 2000 Jul 15; 31(1):208-9. PubMed ID: 10913433
    [No Abstract] [Full Text] [Related]

  • 20. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
    Dobbs TE, Patel M, Waites KB, Moser SA, Stamm AM, Hoesley CJ.
    J Clin Microbiol; 2006 Sep 15; 44(9):3368-70. PubMed ID: 16954275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.